NO20020731L - Kosttilskudd for å forbedre den muskul¶re energimetabolismen som innbefatter en alkanoylkarnitin og ribose - Google Patents

Kosttilskudd for å forbedre den muskul¶re energimetabolismen som innbefatter en alkanoylkarnitin og ribose

Info

Publication number
NO20020731L
NO20020731L NO20020731A NO20020731A NO20020731L NO 20020731 L NO20020731 L NO 20020731L NO 20020731 A NO20020731 A NO 20020731A NO 20020731 A NO20020731 A NO 20020731A NO 20020731 L NO20020731 L NO 20020731L
Authority
NO
Norway
Prior art keywords
ribose
energy metabolism
alkanoylcarnitine
supplements
muscular energy
Prior art date
Application number
NO20020731A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020731D0 (no
Inventor
Pietro Pola
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of NO20020731D0 publication Critical patent/NO20020731D0/no
Publication of NO20020731L publication Critical patent/NO20020731L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/02—Monosaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO20020731A 2000-06-14 2002-02-13 Kosttilskudd for å forbedre den muskul¶re energimetabolismen som innbefatter en alkanoylkarnitin og ribose NO20020731L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000323A IT1317043B1 (it) 2000-06-14 2000-06-14 Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
PCT/IT2001/000283 WO2001095915A1 (en) 2000-06-14 2001-06-01 Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose

Publications (2)

Publication Number Publication Date
NO20020731D0 NO20020731D0 (no) 2002-02-13
NO20020731L true NO20020731L (no) 2002-04-11

Family

ID=11454786

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020731A NO20020731L (no) 2000-06-14 2002-02-13 Kosttilskudd for å forbedre den muskul¶re energimetabolismen som innbefatter en alkanoylkarnitin og ribose

Country Status (19)

Country Link
US (4) US20030108537A1 (es)
EP (1) EP1292312B1 (es)
AT (1) ATE265216T1 (es)
AU (1) AU782367B2 (es)
CA (1) CA2381339C (es)
CZ (1) CZ2002366A3 (es)
DE (1) DE60103055T2 (es)
DK (1) DK1292312T3 (es)
ES (1) ES2219531T3 (es)
HU (1) HU228642B1 (es)
IL (1) IL148038A0 (es)
IT (1) IT1317043B1 (es)
MX (1) MXPA02001550A (es)
NO (1) NO20020731L (es)
PL (1) PL199641B1 (es)
PT (1) PT1292312E (es)
SK (2) SK287308B6 (es)
TR (1) TR200401096T4 (es)
WO (1) WO2001095915A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20020545A1 (it) * 2002-10-30 2004-04-30 Chementecno Srl Integratore energetico e vitaminico minerale ad azione ergogenica per la prevenzione della fatica muscolare.
GB0306394D0 (en) * 2003-03-20 2003-04-23 Univ Nottingham Carnitine retention
WO2004112511A2 (en) * 2003-06-26 2004-12-29 Mcleod Donald M Supplement for restoring growth hormone levels
GB0606864D0 (en) * 2006-04-05 2006-05-17 Univ Nottingham Increades fatty acid oxidation
ES2352154T3 (es) * 2007-01-23 2011-02-16 Bioenergy Inc. Uso de d-ribosa para tratar arritmias cardiacas.
CN101356971B (zh) * 2007-07-30 2012-11-07 石药集团中奇制药技术（石家庄）有限公司 一种用于抗疲劳耐缺氧的保健食品组合物
CA2734769A1 (en) * 2008-08-20 2010-02-25 Bioenergy, Inc. Use of d-ribose for fatigued subjects
GB2510374A (en) * 2013-01-31 2014-08-06 Christopher Francis Bennett Formulation comprising N-acetylcarnitine and D-ribose
GB201304112D0 (en) * 2013-03-07 2013-04-24 Univ Nottingham Modulation of energy expenditure
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
WO2017075289A1 (en) 2015-10-27 2017-05-04 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
ITUB20155250A1 (it) * 2015-11-24 2017-05-24 Apuzzo Dario Nuova composizione nutraceutica, somministrabile per via orale, utile per esercitare una potente stimolazione del metabolismo, in particolare del metabolismo energetico muscolare.
DE102016002090A1 (de) 2016-02-22 2017-08-24 Ribomedica S. L. Komposition für die Nahrungsergänzung menschlicher Ernährung und deren Verwendung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE88631T1 (de) * 1986-09-17 1993-05-15 Clintec Nutrition Co Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
US5397786A (en) * 1993-01-08 1995-03-14 Simone; Charles B. Rehydration drink
IT1291127B1 (it) 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
DE69929128T2 (de) * 1998-08-31 2006-06-29 Nipro Corp. Nährstoffinfusionspräparat
US6579544B1 (en) * 2000-05-31 2003-06-17 Nutriex, L.L.C. Method for supplementing the diet

Also Published As

Publication number Publication date
US20100189704A1 (en) 2010-07-29
CA2381339C (en) 2009-08-11
MXPA02001550A (es) 2002-08-30
TR200401096T4 (tr) 2004-07-21
ES2219531T3 (es) 2004-12-01
IL148038A0 (en) 2002-09-12
US20130309216A1 (en) 2013-11-21
IT1317043B1 (it) 2003-05-26
HUP0202496A2 (hu) 2002-11-28
WO2001095915A1 (en) 2001-12-20
HU228642B1 (hu) 2013-04-29
US20030108537A1 (en) 2003-06-12
SK2102002A3 (en) 2002-05-09
EP1292312B1 (en) 2004-04-28
AU7448701A (en) 2001-12-24
SK17292002A3 (sk) 2003-04-01
EP1292312A1 (en) 2003-03-19
US8747906B2 (en) 2014-06-10
ATE265216T1 (de) 2004-05-15
DE60103055T2 (de) 2004-10-14
NO20020731D0 (no) 2002-02-13
DE60103055D1 (de) 2004-06-03
US8518455B2 (en) 2013-08-27
AU782367B2 (en) 2005-07-21
ITRM20000323A1 (it) 2001-12-14
CZ2002366A3 (cs) 2002-07-17
US20070116743A1 (en) 2007-05-24
ITRM20000323A0 (it) 2000-06-14
PL199641B1 (pl) 2008-10-31
PT1292312E (pt) 2004-08-31
PL352578A1 (en) 2003-08-25
HUP0202496A3 (en) 2005-02-28
DK1292312T3 (da) 2004-08-16
SK287308B6 (sk) 2010-06-07
CA2381339A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
NO20020731L (no) Kosttilskudd for å forbedre den muskul¶re energimetabolismen som innbefatter en alkanoylkarnitin og ribose
DE69815323D1 (de) Therapeutische nahrung für diabätiker
GB2352175B (en) Ribose to prevent cramping and soreness in muscles
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
SG146643A1 (en) Treating or preventing restless legs syndrome using prodrugs of gaba analogs
KR970702738A (ko) 열 및 근육 운동의 결합 작용에 의하여 신체의 특정 부위의 지방 조직을 감소시키기 위한 방법 및 장치
PT739212E (pt) Utilizacao de interleucina-12 para a prevencao de doenca causada pela reaccao do enxerto contra o hospedeiro
MXPA05006629A (es) Formas de dosificacion que contienen un inhibidor de bomba de protones, un nsaid y un amortiguador.
GB2396108B (en) Treatment of pain
AR032248A1 (es) Preparacion para mejorar la asimilacion de los alimentos
EA200501758A1 (ru) Устройство для тренировки мышц влагалища
MX2008001510A (es) Metodos y composiciones para tratar la infertilidad femenina usando clomifeno.
ES2195902T3 (es) Composicion que comprende esfingomielinasa alcalina para uso como preparacion dietetica, complemento alimenticio o producto farmaceutico.
HK1039048A1 (en) Operation of a vertebral axial decompression table.
MXPA05001717A (es) Productos alimenticios que contienen proteina animal, que tienen retencion de humedad mejorada.
MXPA02011472A (es) Combinacion farmaceutica de bicalutamida y tamoxifeno para proporcionar un efecto anti-androgenico y un efecto anti-estrogenico.
NO20022574L (no) N¶ringsmiddel som innbefatter karnitin, som er egnet for å stimulere biosyntesen av polyumettede fettsyrer fra mettedefettsyrer som foreligger i n¶ringsmiddelet
PL362577A1 (en) Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity
ES2166724A1 (es) Salsas dieteticas a base de quitosano.
GB2377639A (en) A combination of pinitol and creatine to enhance uptake and retention of creatine
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
Yongshan et al. A Quantitative Analysis of Muscle Strength in Lumh Nerve Root Compression
UA144809U (uk) Гепатопротекторний засіб
Rourke et al. Effect of calcium supplementation on bone mineral density in women athletes
Kubota Tracing the Foundation of the JSHP (Minutes of the Meeting)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application